| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.096 | 0.02 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.33 | 0.03 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.03 |